Who owns Orexigen Therapeutics?

Key details on Orexigen Therapeutics (Ticker: OREX)

Who owns Orexigen Therapeutics?

Is OREX a good stock to own? Find out who bought Orexigen Therapeutics, who sold Orexigen Therapeutics (OREX) stock, and who holds a large position in Orexigen Therapeutics.

Fund Name Number of Shares Share Valuation As Of
FMR 10.13M $43.16M Sept. 30, 2014
Capital Research Global Investors^ 9.66M $59.69M June 30, 2014
Partner Fund Management 4.84M $20.61M Sept. 30, 2014
STATE STREET CORPORATION 4.79M $20.41M Sept. 30, 2014
T. Rowe Price Associates 4.79M $29.58M June 30, 2014
BlackRock Fund Advisors 4.44M $18.93M Sept. 30, 2014
S.A.C. Capital Advisors 4.30M $24.20M Dec. 31, 2013
Franklin Resources 4.02M $17.13M Sept. 30, 2014
Vanguard 3.73M $15.91M Sept. 30, 2014
NEA Management Company 3.71M $15.80M Sept. 30, 2014
BlackRock Institutional Trust Company, N.A. 3.43M $14.61M Sept. 30, 2014
FIRST MANHATTAN 2.81M $17.37M June 30, 2014
Farallon Capital Management 2.68M $17.45M March 31, 2014
Bank of America Corporation 2.57M $10.96M Sept. 30, 2014
SUSQUEHANNA INTERNATIONAL 2.53M $10.77M Sept. 30, 2014
Millennium Management 2.36M $15.33M March 31, 2014
Samlyn Capital 2.30M $9.79M Sept. 30, 2014
RS INVESTMENT MANAGEMENT 2.23M $9.50M Sept. 30, 2014
FIL 2.21M $14.34M March 31, 2014
Meditor 2.10M $12.87M Sept. 30, 2013
Palo Alto Investors 1.93M $8.23M Sept. 30, 2014
FRED ALGER MANAGEMENT 1.78M $11.57M March 31, 2014
Deutsche Bank Aktiengesellschaft 1.76M $10.79M June 30, 2014
CQS Cayman Limited Partnership 1.75M $7.46M Sept. 30, 2014
COLUMBIA PARTNERS L L C INVESTMENT MANAGEMENT 1.70M $7.24M Sept. 30, 2014
Visium Asset Management 1.67M $9.77M June 30, 2013
UBS GLOBAL ASSET MANAGEMENT AMERICAS 1.66M $7.08M Sept. 30, 2014
Credit Suisse AG 1.55M $6.61M Sept. 30, 2014
D. E. Shaw & Co 1.55M $8.72M Dec. 31, 2013
NORTHERN TRUST 1.40M $5.97M Sept. 30, 2014
Diamondback Capital Management 1.38M $7.63M June 30, 2012
I.G. Investment Management 1.35M $5.76M Sept. 30, 2014
CITADEL ADVISORS 1.35M $8.26M Sept. 30, 2013
QVT Financial 1.32M $8.60M March 31, 2014
Adage Capital Partners GP 1.30M $7.44M Sept. 30, 2012

Who sold Orexigen Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Redmile March 31, 2013 1.35M $8.42M
Daniel D. Thurber Dec. 31, 2010 1.95M $15.79M